Latest Period
Q1 2026
Security Snapshot
Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) Institutional Ownership
CUSIP: 08205P209
13F Institutional Holders and Ownership History from Q3 2023 to Q1 2026
Institutions Reporting
88
Shares (Excl. Options)
32,392,773
Price
$10.65
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001
- Symbol
- BNTC on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 32,392,773
- Total 13F value
- $345,066,052
- Portfolio coverage rank
- 0%
- Share change
- +676,426
- Value change
- +$4,592,772
- Number of holders
- 88
- Shares outstanding
- 35,393,481
- SEC-reported price per share
- $13.99
- Insider filing price
- $13.99
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 is tracked under CUSIP 08205P209.
- 88 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 71 to 88 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $426,562,132 to $345,066,052.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 88 institutions filings for Q1 2026.
Security key
08205P209
Latest holder period
Q1 2026
13F holders
88
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
BNTC full holder history
Benitec Biopharma Inc. SEC filings
Benitec Biopharma Inc. company facts
Benitec Biopharma Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 08205P209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
BNTC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 44% | -12% | $249,200,088 | +$30,000,153 | 17,761,945 | +14% | SUVRETTA CAPITAL MANAGEMENT, LLC | 07 Nov 2025 |
| FRANKLIN RESOURCES INC | 11% | -29% | $50,561,782 | -$5,287,404 | 3,751,709 | -9.5% | Franklin Resources, Inc. | 31 Dec 2025 |
| JANUS HENDERSON GROUP PLC | 10% | -12% | $44,484,293 | -$292,158,468 | 3,382,836 | -87% | JANUS HENDERSON GROUP PLC | 28 Nov 2025 |
| RA CAPITAL MANAGEMENT, L.P. | 5.5% | $24,327,500 | 1,850,000 | RA Capital Management, L.P. | 07 Nov 2025 | |||
| HBM Healthcare Investments (Cayman) Ltd. | 4.5% | $14,156,282 | 1,041,669 | HBM Healthcare Investments (Cayman) Ltd. | 31 Dec 2024 | |||
| Nantahala Capital Management, LLC | 4.4% | -53% | $14,111,462 | 1,038,371 | 0% | Nantahala Capital Management, LLC | 31 Mar 2025 |
As of 31 Mar 2026, 88 institutional investors reported holding 32,392,773 shares of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC). This represents 92% of the company’s total 35,393,481 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
88%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 33% | 11,548,351 | 0% | 3.3% | $122,989,938 |
| JANUS HENDERSON GROUP PLC | 8.1% | 2,876,380 | -1.2% | 0.01% | $30,719,738 |
| FRANKLIN RESOURCES INC | 6.7% | 2,378,159 | +8.2% | 0.01% | $25,327,390 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6% | 2,120,672 | 0% | 0.03% | $22,585,157 |
| RA CAPITAL MANAGEMENT, L.P. | 5.2% | 1,850,000 | 0% | 0.21% | $19,702,500 |
| Nantahala Capital Management, LLC | 4.1% | 1,438,371 | +39% | 0.96% | $15,318,651 |
| BlackRock, Inc. | 3.4% | 1,185,741 | +19% | 0% | $12,628,141 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.6% | 931,556 | 0% | 0% | $9,921,071 |
| INFINITUM ASSET MANAGEMENT, LLC | 2.6% | 923,006 | +2.7% | 1.2% | $9,830,014 |
| Alyeska Investment Group, L.P. | 2.1% | 750,000 | 0% | 0.02% | $7,987,500 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2% | 717,725 | -1.9% | 0.9% | $7,643,771 |
| Balyasny Asset Management L.P. | 1.8% | 653,835 | +0.35% | 0.01% | $6,963,343 |
| MILLENNIUM MANAGEMENT LLC | 1.8% | 652,064 | +6.3% | 0.01% | $6,944,482 |
| Simplify Asset Management Inc. | 1.6% | 562,242 | +272% | 0.09% | $5,987,877 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5% | 524,104 | +16% | 0% | $5,583,031 |
| STATE STREET CORP | 0.96% | 338,249 | +38% | 0% | $3,602,352 |
| AMERIPRISE FINANCIAL INC | 0.9% | 318,346 | +13% | 0% | $3,390,386 |
| MYDA Advisors LLC | 0.64% | 225,000 | 0% | 0.57% | $2,396,250 |
| GOLDMAN SACHS GROUP INC | 0.61% | 215,476 | +24% | 0% | $2,294,820 |
| AWM Investment Company, Inc. | 0.53% | 187,977 | -34% | 0.22% | $2,001,955 |
| VANGUARD FIDUCIARY TRUST CO | 0.49% | 171,753 | 0% | 0% | $1,829,169 |
| CITADEL ADVISORS LLC | 0.49% | 171,722 | +877% | 0% | $1,828,839 |
| NORTHERN TRUST CORP | 0.44% | 157,324 | +25% | 0% | $1,675,501 |
| Schonfeld Strategic Advisors LLC | 0.43% | 153,179 | -42% | 0.01% | $1,631,356 |
| Burkehill Global Management, LP | 0.42% | 150,000 | 0% | 0.08% | $1,597,500 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
11
Latest
Q1 2026
Rows shown
1-11 of 11
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 32,392,773 | $345,066,052 | +$4,592,772 | $10.65 | 88 |
| 2025 Q4 | 31,662,101 | $426,562,132 | +$113,780,072 | $13.47 | 71 |
| 2025 Q3 | 23,155,291 | $324,725,438 | +$6,865,174 | $14.03 | 55 |
| 2025 Q2 | 22,685,530 | $265,306,276 | +$16,737,178 | $11.70 | 56 |
| 2025 Q1 | 21,243,183 | $277,395,506 | +$28,289,371 | $13.01 | 37 |
| 2024 Q4 | 18,997,897 | $240,166,135 | +$64,576,294 | $12.63 | 30 |
| 2024 Q3 | 13,715,023 | $126,792,177 | +$73,385,856 | $9.19 | 25 |
| 2024 Q2 | 5,729,459 | $39,940,820 | +$31,087,038 | $6.99 | 18 |
| 2024 Q1 | 1,270,837 | $6,576,960 | +$379,920 | $5.25 | 13 |
| 2023 Q4 | 1,197,615 | $3,880,452 | -$214,565 | $3.23 | 13 |
| 2023 Q3 | 1,267,947 | $3,838,114 | +$3,838,114 | $3.02 | 11 |